Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.110ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.320ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.91ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.55.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LQ.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDKENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.120 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DT.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DS.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBKENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.14.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used